<DOC>
	<DOCNO>NCT01269450</DOCNO>
	<brief_summary>Working hypothesis aim : To investigate whether progesterone treatment affect incidence preterm labor compare placebo , among woman 2nd trimester bleeding . The participant allocate randomization study control group . Women study group receive micronized progesterone 200 mg ( Utrogestan , company ) intra-vaginal tablet daily control group receive placebo . Both woman medical staff blind group allocation . Treatment commence day inclusion study , 16 week continue 36 week gestation . Data collect conclusion pregnancy regard maternal neonatal outcome .</brief_summary>
	<brief_title>Progesterone Second Trimester Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Viable pregnancy Gestational age 13 26 week Vaginal bleed uterine origin Singleton pregnancy Normal clotting test Hemodynamically stable woman Water leak Signs preterm labor Fetal malformation incompatible life Uterine malformation maternal condition , i.e . liver disease , breast cancer , active thromboembolic state Past preterm birth</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>second trimester vaginal bleeding</keyword>
	<keyword>late abortion</keyword>
	<keyword>preterm birth</keyword>
	<keyword>progesterone</keyword>
</DOC>